[Molecular diagnosis and combined lipid lowering therapy of heterozygous familial hypercholesterolemia. Report of one case].

Rev Med Chil

Departamentos de Diabetes, Nutrición y Metabolismo, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.

Published: February 2007

Heterozygous familial hypercholesterolemia affects one every 400 individuals, is caused by mutations in the LDL receptor gene and is associated with premature coronary artery disease. Nowadays, LDL cholesterol can be efficiently reduced with the new therapies to reduce blood lipids. We report a female patient who consulted in 1975, when she was 46 years old, for severe hypercholesterolemia. In 2003, a sample of leukocyte DNA was obtained and the uncommon 1705+1G>A mutation of the LDL receptor gene was detected. No mutations in the apolipoprotein B gene were found. The patient was treated successfully with simvastatin 80 mg/day and ezetimibe 10 mg/day and LDL cholesterol levels were reduced below 200 mg/dl.

Download full-text PDF

Source
http://dx.doi.org/10.4067/s0034-98872007000200011DOI Listing

Publication Analysis

Top Keywords

heterozygous familial
8
familial hypercholesterolemia
8
ldl receptor
8
receptor gene
8
ldl cholesterol
8
[molecular diagnosis
4
diagnosis combined
4
combined lipid
4
lipid lowering
4
lowering therapy
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!